Controversial Drug DCA to Get First Human Trials

Published: Sep 28, 2007

A potential anti-cancer treatment that attracted massive public interest earlier this year is to be tested on 50 people with brain tumours. The drug, dichloroacetate (DCA), disables the energy-producing mechanism in cancerous cells, although concerns remain over toxicity and side effects such as nerve damage.

Back to news